ICYMI: Rachel Bonesteel on ACO REACH 🎙️

View in browser ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Dear John,

ICYMI, Rachel Bonesteel joined Health Affairs This Week to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to participate in an advanced, global-risk, population-based payment model.

Listen
([link removed] )

Today's Featured Articles

Associations Between Dependent-Related Job Lock And Adult Mental And Physical Health ([link removed] )

Tiffany L. Lemon et al.

Extending Enhanced Premium Tax Credits: Where Things Stand ([link removed] )

Katie Keith

part of our Health Policy At A Crossroads series

Former Federal Employees Lead Coalition To Address Antimicrobial Resistance ([link removed] )

Jomana F. Musmar et al.

Modernizing The Medicare Physician Fee Schedule: Non-Paid Activities Call For Hybrid Payment For Primary Care ([link removed] )

Laura Skopec and Robert A. Berenson

Prior Authorization Reform Heats Up ([link removed] )

Leila Sullivan et al.

More on Medicare Physician Fee Schedule

Modernizing The Medicare Physician Fee Schedule, Part 1: The Role Of A Technical Expert Panel ([link removed] )

Robert A. Berenson (July 2025)

Strengths And Weaknesses Of Introducing An Inflation Factor Into The Medicare Physician Fee Schedule ([link removed] )

Michael E. Chernew et al. (December 2024)

The Road To Value Can’t Be Paved With A Broken Medicare Physician Fee Schedule ([link removed] )

Robert A. Berenson and Kevin J. Hayes (July 2024)

Ask the Health Affairs Editors ([link removed] )

Join Health Affairs on December 3 for an exclusive Insider virtual event to hear our editors discuss 2025's most memorable submissions and take audience questions.

Become an Insider today ([link removed] ) to get access to this exclusive event.

Join Us
([link removed] )

Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs: Implications Of The IRA ([link removed] )

In an ahead-of-print article published this month, Tomas J. Philipson and coauthors explore how mandates from the Inflation Reduction Act (IRA) resulted in shortening the exclusivity period used to recoup research and development investments as well as support follow-on innovation.

The study shows that oncology follow-on approvals frequently shift to earlier disease stages, a trend that may be accelerated by IRA-induced incentives.

Read the Article
([link removed] )

AD_44-12_Preorder_Issue_S10off_eNewsletter-banner (1) ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs, 1101 Connecticut Avenue, NW, Suite 500, Washington, DC 20036, United States, 202-408-6801

Manage preferences ([link removed] )